Jeff Burgdorf is the Head of Research at Gate Neurosciences. He also serves as the Associate Director of the Falk Center for Molecular Therapeutics at Northwestern University and a Research Associate Professor in the Department of Biomedical Engineering at Northwestern University. Dr. Burgdorf brings over 20 years of experience and an extensive history of publications and early research across neuroscience discovery, pharmacology, and translational biomarker work, especially in affective disorders. Alongside Dr. Joe Moskal, Jeff is known for extensive contributions in the field of NMDA receptor mechanisms and behavioral pharmacology related to multiple NMDAR modulator compounds currently in clinical development. Recently, Jeff has pioneered research in the Insulin Growth Factor field and discovery and development of the GATE-300 series at Gate Neurosciences.

Dr. Burgdorf received his PhD in Behavioral Neuroscience and BS in Psychology at Bowling Green State University.